How does rifampicin affect exposure to regorafenib and its active metabolites?

Rifampicin 600 mg for 9 days with a single regorafenib 160 mg dose on day 7 reduced regorafenib AUC by approximately 50%, increased mean exposure to active metabolite M-5 three- to four-fold, and left exposure to active metabolite M-2 unchanged.